Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
Acta Oncologica (Stockholm, Sweden)|February 19, 2026
A conceptual health economic modelling framework to assess the cost-effectiveness of molecular target-driven treatment regimens in oncologyOskar Frisell, Eline Aas, Pia Sofie Henkel, et al.
ACS Chemical Biology|April 3, 2026
High-Throughput Phenotypic Screen to Identify FoxP3 Regulators in Primary T CellsQian Wei, Ehsan Hajjar, Selma Cornillot-Clément, et al.
Molecular Oncology|September 8, 2024
Patient-derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathwaysKatharina Bischof, Andrea Cremaschi, Lena Eroukhmanoff, et al.
The Journal of Biological Chemistry|April 12, 2002
Mechanisms of FOXC2- and FOXD1-mediated regulation of the RI alpha subunit of cAMP-dependent protein kinase include release of transcriptional repression and activation by protein kinase B alpha and cAMPMaria K Dahle, Line M Grønning, Anna Cederberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signalingHilde Abrahamsen, George Baillie, Jacob Ngai, et al.
Journal of Cancer Research and Clinical Oncology|April 2, 2026
Precision cancer medicine in Europe: a mixed-methods study on infrastructure for extended molecular diagnosticsPia S Henkel, Kine Pedersen, Kjetil Taskén, et al.
Molecular Oncology|January 22, 2026
The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activityElise Solli, Alessio Bevilacqua, Mathias Wenes, et al.
AIDS (London, England)|March 22, 2006
Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatmentDag Kvale, Vidar Ormaasen, Anne-Marte Bakken Kran, et al.
Molecular Cell|November 4, 2006
Molecular basis of AKAP specificity for PKA regulatory subunitsMatthew G Gold, Birgitte Lygren, Pawel Dokurno, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 16, 2016
Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 CountsBirgitte Stiksrud, Kristina Berg Lorvik, Dag Kvale, et al.
Pageof 17